Laurent Hoffer

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Convolutional Neural Network

Magnetic Resonance

Top Venues

Nucleic acids research

Nature communications

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Laurent Hoffer, Guillaume Charifi-Hoareau, Sarah Barelier, Stéphane Betzi, Thomas W Miller, Xavier Morelli, Philippe Roche
ChemoDOTS: a web server to design chemistry-driven focused libraries. Nucleic acids research (2024)
Laurent Hoffer, Guillaume Charifi-Hoareau, Sarah Barelier, Stéphane Betzi, Thomas W Miller, Xavier Morelli, Philippe Roche
ChemoDOTS: a web server to design chemistry-driven focused libraries. Nucleic acids research 52 (W1) (2024)
Laurent Hoffer, Guillaume Charifi-Hoareau, Sarah Barelier, Stéphane Betzi, Thomas W Miller, Xavier Morelli, Philippe Roche
ChemoDOTS: a web server to design chemistry-driven focused libraries. Nucleic acids research 52 (W1) (2024)
Magali Saez-Ayala, Laurent Hoffer, Sébastien Abel, Khaoula Ben Yaala, Benoit Sicard, Guillaume P Andrieu, Mehdi Latiri, Emma K Davison, Marco A Ciufolini, Paul Brémond, Etienne Rebuffet, Philippe Roche, Carine Derviaux, Edwige Voisset, Camille Montersino, Remy Castellano, Yves Collette, Vahid Asnafi, Stéphane Betzi, Patrice Dubreuil, Sébastien Combes, Xavier Morelli
From a drug repositioning to a structure-based drug design approach to tackle acute lymphoblastic leukemia. Nature communications 14 (1) (2023)
Jeremy Ariey-Bonnet, Kendall Carrasco, Marion Le Grand, Laurent Hoffer, Stéphane Betzi, Mikael Feracci, Philipp Tsvetkov, François Devred, Yves Collette, Xavier Morelli, Pedro J Ballester, Eddy Pasquier
In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor. Molecular oncology 14 (12) (2020)